A novel treatment that uses a disintegrating matrix for sustained release of medication led to improvement in vision and reduced supplemental treatment in patients with diabetic macular edema, ...
Ocugen also reported updated results from a phase 1 trial, which showed that ellipsoid zone (EZ) loss – which results in the ...
Taking control of Ocular would also give Sanofi access to its drug delivery platform Elutyx, which could have applications ...
Eyecare and eyewear is the focus at this new Bryn Mawr business offering treatments for dry eye, aesthetic ocular ...
Smithsonian Magazine on MSN
Greenland sharks can survive for centuries—and maintain long-lasting vision, despite living in the dark
Greenland sharks—the longest-living vertebrates in the world—dwell in the deep, frigid waters of the Arctic and North ...
Many genetic variants linked to inherited eye disorders rarely lead to disease, meaning up to 2% of people could carry these variants without ever developing vision problems, according to a new s tudy ...
Robert Knox Thomas, the driver who ran over two women with his Rolls-Royce SUV in Napa, is launching his own legal battle to ...
Napa Valley tycoon Robert Knox Thomas, 79, allegedly plowed his $400,000 Rolls-Royce into two women during a downtown ...
Adults over the age of 30 are facing an increased risk of several chronic conditions. This makes health screenings essential ...
FDA alerts and updates on the latest drug and device approvals, recalls, and other regulatory developments in ophthalmology.
The company has started enrolling patients into a run-in period for the Phase III study, and plans to begin dosing later this ...
The announcement comes on the heels of promising preliminary Phase II data, in which OCU410 reduced lesion growth in patients' eyes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback